Division of General Internal Medicine and Primary Care and Health Policy Research Institute, University of California, Irvine, California, USA.
Diabetes Care. 2011 Mar;34(3):598-600. doi: 10.2337/dc10-1825. Epub 2011 Jan 27.
To examine racial/ethnic differences in the prevalence of depressive symptoms and in provider recognition of depression among Latino, Asian, and non-Hispanic white patients with type 2 diabetes.
Patients (n = 1,209) with type 2 diabetes were recruited from five university-affiliated primary care clinics for an observational study.
Vietnamese American (133, 59.4%) and Mexican American (351, 50.2%) patients were more likely to report symptoms consistent with clinical depression (Center for Epidemiological Studies Depression [CES-D] scale score ≥ 22) than non-Hispanic whites (119, 41.6%; F [2, 1206] = 8.05, P < 0.001). Despite comparable diabetes care, Vietnamese and Mexican patients with high depressive symptoms were less likely to be diagnosed and treated than non-Hispanic whites (all P values < 0.001). Minority patients who reported low levels of trust in their provider were less likely to have been diagnosed or treated for depression (adjusted odds ratio 0.65, 95% CI 0.44-0.98, P < 0.05).
Innovative strategies are needed to improve recognition of depressive symptoms in minority patients.
考察拉丁裔、亚裔和非西班牙裔白种 2 型糖尿病患者中抑郁症状的流行率和提供者对抑郁的识别率的种族/民族差异。
从五所大学附属的初级保健诊所招募了 1209 名 2 型糖尿病患者,进行一项观察性研究。
与非西班牙裔白人(119 名,41.6%;F[2,1206]=8.05,P<0.001)相比,越南裔美国人(133 名,59.4%)和墨西哥裔美国人(351 名,50.2%)患者更有可能报告与临床抑郁一致的症状(流行病学研究中心抑郁量表评分≥22)。尽管糖尿病护理相当,但高抑郁症状的越南裔和墨西哥裔患者被诊断和治疗的可能性低于非西班牙裔白人(所有 P 值均<0.001)。报告对提供者信任度低的少数族裔患者被诊断或治疗抑郁的可能性较低(调整后的优势比 0.65,95%置信区间 0.44-0.98,P<0.05)。
需要创新策略来提高对少数族裔患者抑郁症状的识别率。